The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Venlatev 150 mg hard prolonged-release capsules

Teva B.V.PA1986/099/003

Main Information

Trade NameVenlatev 150 mg hard prolonged-release capsules
Active SubstancesVenlafaxine
Dosage FormProlonged-release capsule, hard
Licence HolderTeva B.V.
Licence NumberPA1986/099/003

Group Information

ATC CodeN06AX16 venlafaxine


License statusAuthorised
Licence Issued16/04/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0026-062-030
Interchangeable List DocumentPDF of Interchangeable List
« Back